#National Institutes of Health

The study, sponsored by the National Institutes of Health, will gather data on tecovirimat, or TPOXX.

Higher levels of viral antigens in the blood correlated with more severe disease.

An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.

A challenge for the public health community is ensuring equitable, efficient distribution of vaccines and treatment.

Fauci led the U.S. HIV research effort for nearly 40 years before becoming the nation’s leading COVID-19 medical advisor.

The roadmap includes improved strategies for vaccination, screening and follow-up care.

Using wastewater to track the emergence of new variants of concern could be faster and less expensive than clinical testing.

Antibody levels decrease substantially within three months after a booster, according to new clinical trial data.

People of European or African ancestry who were hospitalized for COVID-19 are more likely to carry particular genetic variants.

Findings from small NIH study could provide insight into long-term neurological symptoms of COVID-19.

Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.

Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.

NIH study finds high BMI and obesity raise infection risk, but asthma does not.

Women who reported chronic depression before the pandemic were 72% more likely to be hospitalized after COVID-19 diagnosis.

Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.